The primary objective of the study is to evaluate the relative bioavailability of three different prescription processes of SHR4640 tablets in healthy volunteers. The secondary objective of the study is to observe the safety of SHR4640 tablets in healthy subjects.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Cmax
Timeframe: Day1 to Day25
AUC0-t
Timeframe: Day1 to Day25
AUC0-inf(if available)
Timeframe: Day1 to Day25